Spotlight Your Latest GPCR Discoveries
This is an informal session designed to help you connect with your peers in a relaxed atmosphere while forging new and valuable relationships across the GPCR community. With an audience of scientists eager to learn about the latest advances in GPCR biology, target discovery, signaling science, and therapeutic development, you'll have the opportunity to showcase your own research through a dedicated poster presentation. Don't miss the chance to connect, learn, and present.
- Showcase your latest GPCR discoveries to a dedicated audience of scientific leaders and innovators.
- Increase visibility for your research across pharma, biotech, and academic organizations working at the forefront of GPCR drug discovery.
- Engage in meaningful scientific discussions and gain direct feedback on your targets, technologies, and therapeutic approaches.
- Build valuable connections with potential collaborators and partners from across the GPCR community.
How to Submit Your Poster
- You must first register your place to attend the 6th GPCR-Targeted Drug Discovery Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: March 3rd
- Abstract Submission Deadline: February 19th
Click the 'Submit Your Poster' button below.
Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Explore The Full Event Guide
- Explore the complete 2027 agenda, featuring a dedicated focus day deep dive into emerging discovery technologies alongside two days of cutting-edge GPCR science.
- Preview exclusive sessions from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, and University of Miami.
- Discover how the industry is tackling GPCR discovery's biggest challenges, from target validation and signaling biology to AI accountability and biased agonism.
- See who you'll be networking with, including scientific decision-makers from leading pharma, biotech, and academic organizations.
- Identify the sessions, speakers, and networking opportunities most relevant to your programs before you attend.
